Daily News

Democrats: Trump 2-1 E.O. Ignores Regulatory Benefits, Only Counts Costs

February 16, 2017
Key Senate Democrats are calling on President Donald Trump to explain why benefits of regulation are not being considered in his two-for-one executive order aimed at scaling back regulations. In a letter Thursday (Feb.16) to Mark Sandy, acting director of the White House Office of Management and Budget, the Democrats assert Trump is ignoring the benefits of regulations on public health and say the E.O. threatens agencies' abilities to carry out the “will of Congress.” At issue is the president's...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.